Amundi ETF MSCI EMU High Dividend UCITS ETF (CD8)

Currency in EUR
176.04
+0.78(+0.45%)
Real-time Data·
Day's Range
175.56176.20
52 wk Range
147.30177.68

Key Statistics

Morning Star Rating
Risk Rating
Bid / Ask
-
Prev. Close
175.26
Price Open
175.58
Volume
421
Average Vol. (3m)
2,067
1-Year Change
10.80%
Day’s Range
175.56-176.20
52-Week Range
147.30-177.68
Market Cap
36.08B
Expense Ratio
-
How do you feel today about CD8?
Vote to see community's results!
or

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Performance

Name
YTD
3M
1Y
3Y
5Y
10Y
Growth of 10001,0991,0221,0981,4301,5841,866
Fund Return+9.92%+2.2%+9.75%+12.66%+9.63%+6.43%
Rank in Category8411,286806849681237
Percentile Rank608961666336
DHLn5.19%41.030+0.32%304,939
MBGn5.04%53.890+0.34%223,130
AXAF5.04%42.42+0.64%285,548
ALVG4.93%343.46+1.14%34,230
TTEF4.82%52.82+0.80%224,140
SGEF4.77%124.75+1.14%92,249
ENEI4.71%7.699-0.01%1,471,464
AD4.57%34.48+0.09%314,418
CABK4.55%7.969+1.52%1,371,983
SASY4.53%85.59+0.11%127,049

Amundi ETF MSCI EMU High Dividend UCITS ETF Company Profile

Amundi ETF MSCI EMU High Dividend UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management. It invests in the public equity markets of the European Economic and Monetary Union (EMU). The fund uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors. It invests in the dividend-yielding stocks of large-cap and mid-cap companies. The fund seeks to replicate the performance of the MSCI EMU High Dividend Yield Strategy Index, by employing synthetic replication methodology. It was formerly known as Amundi ETF MSCI EMU High Dividend. Amundi ETF MSCI EMU High Dividend UCITS ETF was formed on February 3, 2009 and is domiciled in France.

Industry
-
Sector
-
0
Equity Type
ETF
Market
France

FAQ

How is the performance of CD8?

As of 29 Jul 2025, CD8 is trading at a price of 176.04, with a previous close of 175.26. The stock has fluctuated within a day range of 175.56 to 176.20, while its 52-week range spans from 147.30 to 177.68.

What is the current price of CD8?

The CD8 stock price today is 176.04.

What is the P/E ratio of CD8?

The P/E ratio for CD8 is 10.92.

From a Technical Analysis Perspective, Is CD8 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.